DIAGNOSTIC VALUE OF LOW-FIELD MAGNETIC RESONANCE IMAGING IN THE DETECTION AND CHARACTERIZATION OF PRIMARY AND METASTATIC BRAIN TUMORS
Healthway · 15.08.2026 · 2 (5) · 217-222
DOI: 10.64411/s224s667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Healthway, online erschienen am 15.08.2026. Verfasst von Ravshanov D.M.. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Brain tumors remain a major cause of morbidity and mortality worldwide. High-field MRI is considered the gold standard for neuro-oncological diagnostics; however, its availability is limited in many regions. This study aimed to evaluate the diagnostic capabilities of a low-field 0.2 T MRI system in detecting and characterizing intracranial tumors and to compare the findings with CT data. A retrospective analysis of 14,570 brain examinations performed between 2000 and 2009 identified 678 space-occupying lesions (4.7%). Gliomas, metastases, and meningiomas were the most common tumors. Low-field MRI demonstrated high sensitivity in detecting tumor heterogeneity, cystic degeneration, necrosis, hemorrhage, and contrast enhancement patterns, which were critical for tumor grading. Dynamic contrast-enhanced MRI improved differentiation between benign and malignant tumors. The results indicate that low-field MRI is a valuable, cost-effective tool for neuro-oncological diagnostics, particularly in resource-limited settings.
Zitieren
APA
D.M., R. (2026). DIAGNOSTIC VALUE OF LOW-FIELD MAGNETIC RESONANCE IMAGING IN THE DETECTION AND CHARACTERIZATION OF PRIMARY AND METASTATIC BRAIN TUMORS. Healthway, 2(5), 217-222. https://doi.org/10.64411/s224s667
Vancouver
D.M. R. DIAGNOSTIC VALUE OF LOW-FIELD MAGNETIC RESONANCE IMAGING IN THE DETECTION AND CHARACTERIZATION OF PRIMARY AND METASTATIC BRAIN TUMORS. Healthway. 2026;2(5):217-222. doi:10.64411/s224s667
BibTeX
@article{DM2026,
author = {D.M., Ravshanov},
title = {DIAGNOSTIC VALUE OF LOW-FIELD MAGNETIC RESONANCE IMAGING IN THE DETECTION AND CHARACTERIZATION OF PRIMARY AND METASTATIC BRAIN TUMORS},
journal = {Healthway},
year = {2026},
volume = {2},
number = {5},
pages = {217--222},
doi = {10.64411/s224s667}
}
EUVIMED